Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFenner PLC Regulatory News (FENR)

  • There is currently no data for FENR

Trading Update

7 Jul 2017 07:00

RNS Number : 3743K
Fenner PLC
07 July 2017
 

7 July 2017

Fenner PLC("Fenner" or "the Group")

Trading update

Fenner is providing its customary trading update covering the period from 1 March to 7 July 2017.

The Group has continued to make strong progress, principally in new product development, augmented by a further increase in the US rig count.

Business review

AEP's performance has continued to strengthen across each product area. In particular, our Medical businesses are experiencing strong revenue growth from the development of new customer projects. This provides an encouraging platform for long term growth in line with our plans. In Oil & Gas, the growing order book is now translating into increased sales. Our Industrial businesses are performing ahead of last year, reflecting new product launches.

ECS continues to deliver the planned improvements.

Financing review

Cash flow during the period has remained in line with expectations.

On 1 June, US$90 million of 5.78% Senior Guaranteed Loan Notes matured and, as planned, were repaid at par out of the Group's cash deposits. This will reduce the ongoing interest charge accordingly.

Outlook

Trading across the Group remains positive and, on the basis of the improved outlook, most notably in the medical businesses, the Board anticipates that the Group's operating profit for the financial year ending 31 August 2017 will be comfortably ahead of its previous expectations, with the added benefit of a reduced interest charge going forward.

Financial calendar

The Group expects to release its results for its financial year ending 31 August 2017 on 15 November 2017.

 

For further information please contact:

Fenner PLC

01482 626501

Mark Abrahams, Chief Executive Officer

John Pratt, Group Finance Director

 

Weber Shandwick Financial

020 7067 0700

Nick Oborne / Tom Jenkins

Notes to editors:

Fenner PLC is a world leader in reinforced polymer technology, providing local engineered solutions for performance-critical applications. The Group operates through two divisions:

Advanced Engineered Products: The AEP division is a group of nine businesses that use advanced polymeric materials and technical expertise to provide high value-added solutions to customers' most challenging engineering problems across a variety of markets, generally classified as specialist industrial, medical and oil & gas. AEP's trading names include Hallite, Fenner Precision, Fenner Drives, Secant Group, Charter Medical, CDI Energy Products and EGC Critical Components.

Engineered Conveyor Solutions: The ECS division, trading under the Fenner Dunlop, Fenner and Dunlop brand names, is an established global leader in the supply of heavyweight conveyor belting and related services to the mining, industrial and bulk materials markets. ECS has leading presences in the Northern Hemisphere (principally North America and Europe) and the Southern Hemisphere (principally Australia).

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTLLFFEDSIRIID
Date   Source Headline
7th Jan 20119:20 amRNSHolding(s) in Company
6th Jan 201110:35 amRNSAnnual Information Update
23rd Dec 201012:58 pmRNSHolding(s) in Company
16th Dec 201012:09 pmRNSHolding(s) in Company
9th Dec 20104:01 pmRNSDocuments available for inspection & Notice of AGM
7th Dec 201011:41 amRNSHolding(s) in Company
6th Dec 20107:00 amRNSGroup Announcement
1st Dec 20107:00 amRNSCompletion of JV Arrangements with BBV
29th Nov 20109:56 amRNSDirector/PDMR Shareholding
10th Nov 20107:00 amRNSBoard Changes
10th Nov 20107:00 amRNSFinal Results
5th Nov 20107:00 amRNSAcquisition of BBV
13th Oct 20109:53 amRNSHolding(s) in Company
4th Oct 201012:00 pmRNSNotice of Results
4th Oct 201012:00 pmRNSInvestor Presentation
6th Sep 20107:00 amRNSPre-Close Trading Update
2nd Sep 20109:54 amRNSBlocklisting Interim Review
31st Aug 201010:14 amRNSDirector/PDMR Shareholding
12th Aug 20109:14 amRNSHolding(s) in Company
6th Aug 20102:38 pmRNSHolding(s) in Company
6th Aug 20109:00 amRNSHolding(s) in Company
29th Jul 201011:04 amRNSHolding(s) in Company
19th Jul 20107:00 amRNSInterim Management Statement
8th Jul 20107:00 amRNSAcquisition of MRI Manufacturing & Research, Inc
6th Jul 20109:17 amRNSHolding(s) in Company
18th Jun 20102:52 pmRNSHolding(s) in Company
17th Jun 20107:00 amRNSDirectorate Change
28th May 20109:51 amRNSTotal Voting Rights
12th May 201010:22 amRNSHolding(s) in Company
6th May 20103:51 pmRNSHolding(s) in Company
6th May 201012:36 pmRNSHolding(s) in Company
4th May 20102:59 pmRNSDirector/PDMR Shareholding
4th May 20102:57 pmRNSDirector/PDMR Shareholding
29th Apr 20107:00 amRNSDirector/PDMR Shareholding
28th Apr 20101:02 pmRNSResults of Placing
28th Apr 20107:01 amRNSPlacing of New Ordinary Shares
28th Apr 20107:00 amRNSHalf Year Results
16th Apr 201012:47 pmRNSHolding(s) in Company
8th Apr 20103:40 pmRNSHolding(s) in Company
19th Mar 20107:00 amRNSAppointment of Non-Executive Director
8th Mar 20107:00 amRNSPre-close Trading Update
3rd Mar 20109:19 amRNSBlocklisting Interim Review
13th Jan 20107:00 amRNSAGM and IMS
6th Jan 201010:19 amRNSAnnual Information Update
10th Dec 200911:46 amRNSDocuments available for inspection & Notice of AGM
4th Dec 20099:24 amRNSDirector/PDMR Shareholding
24th Nov 20099:59 amRNSDirector/PDMR Shareholding
18th Nov 20093:40 pmRNSHolding(s) in Company
11th Nov 20097:00 amRNSFinal Results
4th Nov 20093:39 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.